Rapid Micro Biosystems, Inc.
RPID Nasdaq
SEC CIK 1380106
Follow Rapid Micro Biosystems
Weekly email: filings, results, news
Revenue, last quarter
$8.1M
+10.9% vs same quarter last year
Net income
−$12.9M
−9% vs same quarter last year
EPS, diluted
−$0.27
+0% vs same quarter last year
Operating cash flow
−$12.7M
−30.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $33.6M | −$47.1M |
| FY24 | $28.1M | −$46.9M |
| FY23 | $22.5M | −$52.5M |
| FY22 | $17.1M | −$60.8M |
| FY21 | $23.2M | −$73.5M |
| FY20 | $16.1M | −$37.1M |
| FY19 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −141.1% | −140.3% |
| FY24 | −178% | −167.2% |
| FY23 | −251.2% | −233% |
| FY22 | −369% | −354.9% |
| FY21 | −203.3% | −316.5% |
| FY20 | −190% | −230.6% |
| FY19 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$31.9M |
| FY24 | −$45.5M |
| FY23 | −$46.9M |
| FY22 | −$65.3M |
| FY21 | −$58.2M |
| FY20 | −$31.7M |
| FY19 | - |
- Rapid Micro Biosystems
- Technology median
Show the numbers
| Year | Rapid Micro Biosystems | Technology median |
|---|---|---|
| FY25 | −140.3% | −0.4% |
| FY24 | −167.2% | −2.7% |
| FY23 | −233% | −7.5% |
| FY22 | −354.9% | −7.3% |
| FY21 | −316.5% | −4.6% |
| FY20 | −230.6% | −8.8% |
| FY19 | - | −4.7% |